Linezolid Kabi New Zealand - English - Medsafe (Medicines Safety Authority)

linezolid kabi

fresenius kabi new zealand limited - linezolid 2 mg/ml - solution for infusion - 2 mg/ml - active: linezolid 2 mg/ml excipient: citric acid glucose monohydrate hydrochloric acid sodium citrate sodium hydroxide water for injection - indicated for the treatment of infections when known or suspected to be caused by susceptible organisms including those associated with concurrent bacteraemia such as: - pneumonia - community acquired and nosocomial pneumonia - skin and soft tissue infections - enterococcal infections. linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected. consideration should be given to official guidance on the appropriate use of antibacterial agents.

Linezolid Kabi New Zealand - English - Medsafe (Medicines Safety Authority)

linezolid kabi

fresenius kabi new zealand limited - linezolid 2 mg/ml - solution for infusion - 2 mg/ml - active: linezolid 2 mg/ml excipient: citric acid glucose monohydrate hydrochloric acid sodium citrate sodium hydroxide water for injection - indicated for the treatment of infections when known or suspected to be caused by susceptible organisms including those associated with concurrent bacteraemia such as: - pneumonia - community acquired and nosocomial pneumonia - skin and soft tissue infections - enterococcal infections. linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected. consideration should be given to official guidance on the appropriate use of antibacterial agents.

Linezolid Kabi 2mg/ml solution for infusion Malta - English - Medicines Authority

linezolid kabi 2mg/ml solution for infusion

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - linezolid - solution for infusion - linezolid 2 mg/ml - antibacterials for systemic use

LINEZOLID 2 Mg/Ml Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

linezolid 2 mg/ml solution for infusion

fresenius kabi limited - linezolid - solution for infusion - 2 mg/ml - other antibacterials

Linezolid Fresenius Kabi 2 mg/ml inf. sol. i.v. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

linezolid fresenius kabi 2 mg/ml inf. sol. i.v.

fresenius kabi sa-nv - linezolid 2 mg/ml - solution for infusion - 2 mg/ml - linezolid 2 mg/ml - linezolid

Linezolid Fresenius Kabi 2 mg/ml inf. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

linezolid fresenius kabi 2 mg/ml inf. sol. i.v. vial

fresenius kabi sa-nv - linezolid 2 mg/ml - solution for infusion - 2 mg/ml - linezolid 2 mg/ml - linezolid

LINEZOLID KABI linezolid 600 mg/300 mL solution for injection infusion bottle Australia - English - Department of Health (Therapeutic Goods Administration)

linezolid kabi linezolid 600 mg/300 ml solution for injection infusion bottle

fresenius kabi australia pty ltd - linezolid, quantity: 2 mg/ml - injection, intravenous infusion - excipient ingredients: sodium citrate; sodium hydroxide; glucose monohydrate; citric acid; hydrochloric acid; water for injections - linezolid is indicated for the treatment of suspected or proven infections due to gram-positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species.,linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected.

LINEZOLID KABI linezolid 600 mg/300 mL solution for injection infusion bag Australia - English - Department of Health (Therapeutic Goods Administration)

linezolid kabi linezolid 600 mg/300 ml solution for injection infusion bag

fresenius kabi australia pty ltd - linezolid, quantity: 2 mg/ml - injection, intravenous infusion - excipient ingredients: hydrochloric acid; sodium citrate; citric acid; sodium hydroxide; water for injections; glucose monohydrate - linezolid is indicated for the treatment of suspected or proven infections due to gram-positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species.,linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected.

Linezolid Kabi, 2 mg/mL Solution for Infusion Malta - English - Medicines Authority

linezolid kabi, 2 mg/ml solution for infusion

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - solution for infusion - linezolid 2 mg/ml - antibacterials for systemic use

Linezolid 2 mg/ ml solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

linezolid 2 mg/ ml solution for infusion

fresenius kabi deutschland gmbh - linezolid - solution for infusion - 2 milligram(s)/millilitre - other antibacterials; linezolid